Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis

F Schmidt, B Amann, S Schlösser, K Loeschke - Neuropsychobiology, 2000 - karger.com
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-·) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis

M Schafer, F Schmidt, B Amann… - …, 2000 - search.proquest.com
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis

MSF Schmidta, BASSK Loeschkeb… - …, 2000 - search.ebscohost.com
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-α) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

[PDF][PDF] Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective …

MSF Schmidta, BASSK Loeschkeb… - …, 2000 - scholar.archive.org
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-·) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis.

M Schäfer, F Schmidt, B Amann, S Schlösser… - …, 2000 - europepmc.org
Treatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

[引用][C] Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis

M SCHAFER - Neuropsychobiology, 2000 - cir.nii.ac.jp
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved
psychiatric tolerability in a patient with schizoaffective psychosis | CiNii Research CiNii 国立 …

Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis

M Schäfer, F Schmidt, B Amann, S Schlösser… - …, 2000 - karger.com
Treatment of chronic hepatitis C with interferon alpha (IFN-α) is relatively contraindicated in
patients with psychiatric disorders because of possible severe psychiatric side effects. We …

[引用][C] Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis

M SCHÄFER, F SCHMIDT, B AMANN… - …, 2000 - pascal-francis.inist.fr
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved
psychiatric tolerability in a patient with schizoaffective psychosis CNRS Inist Pascal-Francis CNRS …

[PDF][PDF] Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective …

MSF Schmidta, BASSK Loeschkeb, H Grunzea - Neuropsychobiology, 2000 - Citeseer
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-·) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …

Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis

M Schäfer, F Schmidt, B Amann… - …, 2000 - epub.ub.uni-muenchen.de
Abstract Treatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively
contraindicated in patients with psychiatric disorders because of possible severe psychiatric …